However, that we found a stronger impact of IL-2 on inflammation in the lung than in the serum, even when IL-2 was administered systemically, suggests the lung and responses against respiratory infections may be particularly sensitive to IL-2. This evidence concerns the gene IL2 and respiratory tract infectious disorder.